Innate Pharma SA
F:IDDA
Innate Pharma SA
F:IDDA
Price:
1.46
EUR
Market Cap:
€118.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
F:IDDA
|
FR |
|
Celanese Corp
NYSE:CE
|
US |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
|
Berlina Tbk PT
IDX:BRNA
|
ID |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
P
|
Pinnacle West Capital Corp
DUS:PWC
|
US |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
Five Below Inc
NASDAQ:FIVE
|
US |
|
Innate Pharma SA
F:IDD
|
FR |
|
E
|
Enterprise Products Partners LP
LSE:0S23
|
US |
|
U
|
Unity Software Inc
F:US3
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Innate Pharma SA (IDDA) under the Base Case is hidden
EUR.
Compared with the current market price of 1.46 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IDDA Multiples-Based Value
LOCKED
